208 related articles for article (PubMed ID: 34799676)
1. Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.
Yu EY; Zahid SS; Aloe S; Falck-Pedersen E; Zhou XK; Cheung NV; Lue NF
Commun Biol; 2021 Nov; 4(1):1315. PubMed ID: 34799676
[TBL] [Abstract][Full Text] [Related]
2. Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.
Yu EY; Cheung NV; Lue NF
J Hematol Oncol; 2022 Aug; 15(1):117. PubMed ID: 36030273
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
Pediatr Blood Cancer; 2024 Jan; 71(1):e30735. PubMed ID: 37859597
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Sep; ():. PubMed ID: 37693610
[TBL] [Abstract][Full Text] [Related]
5. Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
Huang Y; Tsubota S; Nishio N; Takahashi Y; Kadomatsu K
Cancer Sci; 2021 Feb; 112(2):715-724. PubMed ID: 33277754
[TBL] [Abstract][Full Text] [Related]
6. Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells.
Di Matteo S; Bilotta MT; Pelosi A; Haas D; Theinert T; Weber G; Schlegel PG; Berg M; Moretta L; Maggi E; Azzarone B; Vacca P; Tumino N; Caruana I
Front Immunol; 2024; 15():1382931. PubMed ID: 38736882
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Westerhout EM; Hamdi M; Stroeken P; Nowakowska NE; Lakeman A; van Arkel J; Hasselt NE; Bleijlevens B; Akogul N; Haneveld F; Chan A; van Sluis P; Zwijnenburg D; Volckmann R; van Noesel CJM; Adameyko I; van Groningen T; Koster J; Valentijn LJ; van Nes J; Versteeg R
Cancer Res; 2022 Feb; 82(3):484-496. PubMed ID: 34853072
[TBL] [Abstract][Full Text] [Related]
8. T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
Kaufman ME; Vayani OR; Moore K; Chlenski A; Wu T; Chavez G; Lee SM; Desai AV; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Jun; ():. PubMed ID: 37425883
[TBL] [Abstract][Full Text] [Related]
9. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
van Groningen T; Akogul N; Westerhout EM; Chan A; Hasselt NE; Zwijnenburg DA; Broekmans M; Stroeken P; Haneveld F; Hooijer GKJ; Savci-Heijink CD; Lakeman A; Volckmann R; van Sluis P; Valentijn LJ; Koster J; Versteeg R; van Nes J
Nat Commun; 2019 Apr; 10(1):1530. PubMed ID: 30948783
[TBL] [Abstract][Full Text] [Related]
10. Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.
Jahangiri L; Pucci P; Ishola T; Pereira J; Cavanagh ML; Turner SD
Discov Oncol; 2021 Nov; 12(1):56. PubMed ID: 35201514
[TBL] [Abstract][Full Text] [Related]
11. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
12. Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism.
Kimura S; Sekiguchi M; Watanabe K; Hiwatarai M; Seki M; Yoshida K; Isobe T; Shiozawa Y; Suzuki H; Hoshino N; Hayashi Y; Oka A; Miyano S; Ogawa S; Takita J
PLoS One; 2021; 16(1):e0245526. PubMed ID: 33465163
[TBL] [Abstract][Full Text] [Related]
13. Comparison of telomerase levels before and after differentiation of two cell lines of human neuroblastoma.
Sanborn CK; O'Connor A; Sawin RS; Moore K; Dehart MJ; Azarow KS
J Surg Res; 2000 Oct; 93(2):206-10. PubMed ID: 11027462
[TBL] [Abstract][Full Text] [Related]
14. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel.
van Wezel EM; van Zogchel LMJ; van Wijk J; Timmerman I; Vo NK; Zappeij-Kannegieter L; deCarolis B; Simon T; van Noesel MM; Molenaar JJ; van Groningen T; Versteeg R; Caron HN; van der Schoot CE; Koster J; van Nes J; Tytgat GAM
JCO Precis Oncol; 2019; 3():. PubMed ID: 34036221
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells.
Kraveka JM; Li L; Bielawski J; Obeid LM; Ogretmen B
Arch Biochem Biophys; 2003 Nov; 419(2):110-9. PubMed ID: 14592454
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.
Zhao YM; Li JY; Lan JP; Lai XY; Luo Y; Sun J; Yu J; Zhu YY; Zeng FF; Zhou Q; Huang H
Biochem Biophys Res Commun; 2008 May; 369(4):1114-9. PubMed ID: 18339310
[TBL] [Abstract][Full Text] [Related]
18. Telomere length influences cancer cell differentiation in vivo.
Hirashima K; Migita T; Sato S; Muramatsu Y; Ishikawa Y; Seimiya H
Mol Cell Biol; 2013 Aug; 33(15):2988-95. PubMed ID: 23716593
[TBL] [Abstract][Full Text] [Related]
19. Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.
Wesbuer S; Lanvers-Kaminsky C; Duran-Seuberth I; Bölling T; Schäfer KL; Braun Y; Willich N; Greve B
Radiat Oncol; 2010 Jul; 5():66. PubMed ID: 20642823
[TBL] [Abstract][Full Text] [Related]
20. Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells.
Chapman EJ; Kelly G; Knowles MA
Mol Cancer Res; 2008 Jul; 6(7):1154-68. PubMed ID: 18644980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
